U.S. Physical Therapy (USPH) Set to Announce Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.58 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. The business had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.58 EPS. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Price Performance

USPH opened at $105.20 on Monday. The company has a current ratio of 2.28, a quick ratio of 2.28 and a debt-to-equity ratio of 0.29. The company has a fifty day simple moving average of $105.10 and a 200 day simple moving average of $96.06. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of 77.93, a PEG ratio of 4.99 and a beta of 1.39. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $124.11.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were issued a dividend of $0.44 per share. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend was Monday, March 11th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 130.37%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Clayton Trier sold 400 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.00, for a total transaction of $42,800.00. Following the completion of the transaction, the director now owns 7,000 shares in the company, valued at approximately $749,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other U.S. Physical Therapy news, Director Clayton Trier sold 400 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.00, for a total transaction of $42,800.00. Following the sale, the director now directly owns 7,000 shares in the company, valued at approximately $749,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Edward L. Kuntz sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $104.26, for a total transaction of $260,650.00. Following the completion of the sale, the director now directly owns 5,780 shares of the company’s stock, valued at $602,622.80. The disclosure for this sale can be found here. Insiders have sold a total of 10,829 shares of company stock worth $1,141,535 in the last three months. 1.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have issued reports on USPH shares. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research note on Wednesday, March 13th. Barrington Research lifted their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Finally, StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.